Published in the Journal of Psychoactive Drugs, the Institute’s first article was the first study to examine medical cannabis patients living in Arizona. The findings showed that legalization has had many positive effects on patient outcomes, including increased feelings of safety, improved product knowledge, and greater product effectiveness.
The second study, published in the Journal of Alternative and Complementary Medicine, examined the byproducts produced by vaporizing cannabis-oil cutting agents. The results showed that PEG 400 produced formaldehyde at levels comparable to cigarette smoke, whereas MCT and VG produced negligible levels of harmful byproducts.
Founded by Drs. Troutt and DiDonato, the Medical Marijuana Research Institute is our research division, and is dedicated to contributing to the academic literature on medical marijuana. The Institute’s first article was recently published in the Journal of Psychoactive Drugs, and focuses on the characteristics and experiences of medical marijuana patients in Arizona. Conducting such research establishes Harvest as an industry leader in both business and academia.